DMC.VN DOMESCO Medical Import Export JSC
- Market cap
- VND 1.94T
- P/E
- 10.0x
- P/B
- 1.17x
- ROE
- 13.1%
- Dividend yield
- 4.46%
- Fundamental score
- 2.7/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is DMC.VN undervalued?
Graham numberDMC.VN trades 28.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
DOMESCO Medical Import Export JSC fundamental analysis
14 of 22 checks passedROE 1/2
Moderate return on equity (13.1%), between 10% and 20%.
ROA 0/1
Return on assets (11.1%) is below the industry median (11.7%).
Profit Consistency 2/2
Profitable for 7 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-2.1%) is not above the 5-year average (2.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-2.1%) is below the industry median (5.0%).
Revenue Growth 1/2
Revenue grew 9.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 166.0x against interest expense, well covered.
PE vs Market 1/1
PE (10.0x) is below the market median (11.2x).
PE vs Industry 1/1
PE (10.0x) is below the industry median (13.1x).
PBV 1/1
Price to book (1.2x) is below the industry median (2.2x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 11.7, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 4.96, above 1.
Dividend Yield 1/2
Dividend yield (4.5%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 7 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 43.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
DOMESCO Medical Import Export JSC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About DOMESCO Medical Import Export JSC
Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthet…
Full company profileDOMESCO Medical Import Export JSC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
DOMESCO Medical Import Export JSC annual financial statements (VND; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.47T | 1.45T | 1.50T | 1.59T | 1.72T | 1.90T | 2.07T | 2.08T |
| Gross Profit | 493B | 438B | 402B | 453B | 372B | 417B | 409B | 416B |
| Operating Income | 267B | 203B | 186B | 234B | 183B | 226B | 221B | 238B |
| EBITDA | 321B | 253B | 226B | 275B | 248B | 271B | 268B | 298B |
| Net Income | 233B | 180B | 159B | 200B | 183B | 203B | 198B | 219B |
| EPS | 6,699 | 5,170 | 4,587 | 5,761 | 5,279 | 5,837 | 5,713 | 6,304 |
| Balance Sheet | ||||||||
| Total Assets | 1.53T | 1.46T | 1.62T | 1.84T | 1.85T | 1.84T | 1.92T | 1.97T |
| Total Liabilities | 281B | 149B | 256B | 378B | 329B | 228B | 228B | 296B |
| Shareholders' Equity | 1.25T | 1.32T | 1.37T | 1.46T | 1.52T | 1.61T | 1.69T | 1.68T |
| Cash & Short-term Investments | 98.4B | 108B | 85.4B | 47.5B | 114B | 130B | 75.8B | 37.6B |
| Cash Flow | ||||||||
| Operating Cash Flow | 111B | -44.8B | 162B | 274B | 164B | 15.7B | 161B | -63.5B |
| Capital Expenditure | 35.2B | 14.3B | 6.11B | 10.6B | 7.39B | 41.6B | 36.7B | 11.7B |
| Free Cash Flow | 75.9B | -59.1B | 156B | 263B | 156B | -25.9B | 125B | -75.2B |
| Ratios | ||||||||
| ROE | 18.6% | 13.6% | 11.7% | 13.7% | 12.1% | 12.6% | 11.8% | 13.1% |
| ROA | 15.2% | 12.3% | 9.8% | 10.9% | 9.9% | 11.0% | 10.4% | 11.1% |
| Net Profit Margin | 15.8% | 12.4% | 10.6% | 12.6% | 10.7% | 10.7% | 9.6% | 10.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
DOMESCO Medical Import Export JSC dividends
- Dividend yield
- 4.46%
- Forward dividend
- 2,500.00 VND
- Payout ratio
- 43.8%
- Ex-dividend date
- Sep 14, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | VND 86.8B | 2,500 | 43.8% |
| 2024 | VND 86.8B | 2,500 | 42.8% |
| 2023 | VND 86.8B | 2,500 | 47.4% |
| 2022 | VND 86.8B | 2,500 | 43.4% |
| 2021 | VND 86.8B | 2,500 | 54.5% |
| 2020 | VND 86.8B | 2,500 | 48.4% |
| 2019 | VND 86.8B | 2,500 | 37.3% |
| 2014 | - | - | - |
| 2009 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 13:10 on Jun 16, 2016.
Who owns DOMESCO Medical Import Export JSC
- Insiders 51.79%
- Institutions 34.71%
- Public & others 13.50%
- Shares outstanding 34.7M
DOMESCO Medical Import Export JSC company profile
- Company name
- DOMESCO Medical Import Export JSC
- Ticker
- DMC.VN
- ISIN
- VN000000DMC9
- Exchange
- Vietnam Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 912
- Fiscal year end
- December
- Address
- No. 346, Nguyen Hue Street, Cao Lanh, Vietnam
- Phone
- 84 2 773 852278
- Website
- domesco.com
About DOMESCO Medical Import Export JSC
Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthetic drug products such as, cardiovascular agents; antidiabetics; antibiotics; analgesics and antipyretic drugs; respiratory agents; gastrointestinal drugs; minerals and vitamins; and other synthetic drug products. The company offers its products under the Domesco brand name. The company was founded in 1989 and is headquartered in Cao Lãnh, Vietnam. Domesco Medical Import - Export Joint-Stock Corporation is a subsidiary of Abbott Laboratories(Chile) Holdco SpA.
DOMESCO Medical Import Export JSC management
3- Ms. Giang Thi Huong LuongCEO, Vice Chairwoman, General Director & Member of Management Board · born 1967
- Mr. Tung Duy NguyenCFO & Deputy General Director · born 1969
- Ms. Tuyen Ngoc PhamChief Accountant · born 1969